To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SNRNP200TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
557 supporting clones for gene SNRNP200 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB067751 testis .a -8 to 562 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
NM_014014.3   .a 1 to 7201 8 to 7208 exact RefSeq, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 7208/7208
(100 %)
0 diff
(100 %id)
DB286795 uterus .a 1 to 544 8 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA736639   .a 1 to 754 2 to 756   tiling clone, capped   755/755
(100 %)
6 diff
(99.3 %id)
DA097498 cerebellum .a 8 to 562 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA103659 cerebellum .a 8 to 551 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA185777 amygdala .a 8 to 436 2 to 430   capped   429/436
(98 %)
1 diff
(99.8 %id)
DA331177 hippocampus .a 8 to 575 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA334547 hippocampus .a 8 to 605 2 to 604   capped   603/603
(100 %)
5 diff
(99.2 %id)
DA338444 hippocampus .a 8 to 581 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA437049 tongue, tumor tissue .a 8 to 613 2 to 608   capped   607/607
(100 %)
2 diff
(99.7 %id)
DA437805 tongue, tumor tissue .a 8 to 576 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA443629 tongue, tumor tissue .a 8 to 570 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA457408 tongue, tumor tissue .a 8 to 571 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA769864 brain .a 8 to 569 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA773257 brain .a 8 to 550 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA790072 brain .a 8 to 520 2 to 516   capped   515/515
(100 %)
3 diff
(99.5 %id)
DB168829 kidney, tumor tissue .a 8 to 589 2 to 586   capped   585/585
(100 %)
4 diff
(99.4 %id)
DB278500 uterus .a 8 to 542 2 to 539   capped   538/538
(100 %)
3 diff
(99.5 %id)
DB279851 uterus .a 8 to 545 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DB287755 uterus .a 8 to 583 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
BE145572 head_neck .a 9 to 343 2 to 336       335/336
(99 %)
5 diff
(98.6 %id)
DA189595 amygdala .a 9 to 581 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA322928 hippocampus .a 11 to 474 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
DA807579 brain .a 11 to 563 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB159863 thymus .a 15 to 611 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DB280542 uterus .a 15 to 553 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA339104 hippocampus .a 24 to 618 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
AY572488   .a 38 to 6806 1 to 6769 S1087L     6769/6769
(100 %)
2 diff
(100.0 %id)
DA328881 hippocampus .a 46 to 592 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA339025 hippocampus .a 46 to 592 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA455471 tongue, tumor tissue .a 46 to 611 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA773150 brain .a 46 to 630 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DB069242 testis .a 46 to 585 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DB109719 thymus .a 46 to 631 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA492418 brain .a 76 to 643 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AB018331 brain .a 446 to 7199 1 to 6754   tiling clone, available from KIAA,   6754/6754
(100 %)
0 diff
(100 %id)
DB141693 thymus .a 536 to 1064 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
BF592627 breast, lobullar carcinoma in situ .a 563 to 782 220 to 1       220/220
(100 %)
13 diff
(94.1 %id)
BC112891 Testis, embryonal carcinoma .a 863 to 6801 1 to 5939   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 5939/5939
(100 %)
1 diff
(100.0 %id)
BQ215009 embryonal carcinoma, cell line, testis .a 864 to 1692 1 to 839       839/881
(95 %)
12 diff
(98.7 %id)
BM449460 eye, retinoblastoma .a 871 to 1631 1 to 765       765/1073
(71 %)
8 diff
(99.3 %id)
AK024391 placenta .a 903 to 6801 1 to 5898   available from FLJ,   5898/5898
(100 %)
9 diff
(99.9 %id)
AU140799 placenta .a 904 to 1608 2 to 708   capped   707/709
(99 %)
13 diff
(98.2 %id)
AK023840 placenta .a 972 to 6806 1 to 5834   available from FLJ,   5834/5834
(100 %)
17 diff
(99.8 %id)
AU140885 placenta .a 973 to 1683 2 to 712   capped   711/712
(99 %)
2 diff
(99.8 %id)
DB149215 thymus .a 985 to 1548 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA720879   .a 1142 to 1714 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA864991 placenta .a 1171 to 1717 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
AL831994 human skeletal muscle .a 1268 to 6806 1 to 5539   available from DKFZ, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 5539/5539
(100 %)
8 diff
(99.9 %id)
DA059787 cerebellum .a 1431 to 1997 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB075235 testis .a 1489 to 2021 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
AU140773 placenta .a 1495 to 2274 2 to 782   capped   781/830
(94 %)
2 diff
(99.8 %id)
AL560734 B cells from Burkitt lymphoma .a 1503 to 2482 1 to 979       979/979
(100 %)
1 diff
(99.9 %id)
BM478548 embryonal carcinoma, cell line, testis .a 1527 to 2410 1 to 891       891/1036
(86 %)
21 diff
(98.0 %id)
AJ844618   .a 1629 to 1862 1 to 234       234/234
(100 %)
0 diff
(100 %id)
CN394291 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1668 to 2186 1 to 519       519/519
(100 %)
0 diff
(100 %id)
BM451396 eye, retinoblastoma .a 1760 to 2667 1 to 913       913/1044
(87 %)
14 diff
(98.7 %id)
DA852514 placenta .a 1811 to 2371 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CD359937 testis .a 1894 to 2668 1 to 778       778/872
(89 %)
5 diff
(99.5 %id)
BM477502 lymph, lymphoma, cell line .a 1930 to 2868 1 to 949       949/1044
(90 %)
20 diff
(98.1 %id)
DA231204 brain .a 1968 to 2510 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
CN394286 embryonic stem cells, DMSO-treated H9 cellline .a 2143 to 2664 1 to 522       522/522
(100 %)
0 diff
(100 %id)
DA850756 placenta .a 2198 to 2734 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA491988 brain .a 2205 to 2760 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB163036 thymus .a 2400 to 2995 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA550882   .a 2420 to 3175 2 to 753   capped   752/833
(90 %)
7 diff
(99.2 %id)
DA057439 cerebellum .a 2546 to 3156 2 to 612   capped   611/611
(100 %)
0 diff
(100 %id)
CN394305 embryonic stem cells, cell lines H1, H7, andH9 .a 2556 to 3228 1 to 673       673/673
(100 %)
0 diff
(100 %id)
BM541248 leiomyosarcoma, uterus .a 2612 to 3600 1 to 996       996/1065
(93 %)
15 diff
(98.6 %id)
TI_154167274   .a 2656 to 3228 78 to 654       577/799
(72 %)
23 diff
(97.2 %id)
BF946233 nervous_normal .a 2725 to 2848 1 to 120       120/125
(96 %)
11 diff
(91.2 %id)
CF138900 lymph .a 2741 to 2892 1 to 152       152/152
(100 %)
7 diff
(95.4 %id)
DB288410 uterus .a 2777 to 3323 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA720498   .a 2826 to 3391 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA315723 hippocampus .a 2834 to 3402 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA319918 hippocampus .a 2843 to 3392 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
TI_154154844   .a 2861 to 3531 79 to 749       671/673
(99 %)
17 diff
(97.5 %id)
TI_154167984   .a 2868 to 3367 80 to 579       500/500
(100 %)
3 diff
(99.4 %id)
TI_59380939   .a 2911 to 3373 125 to 590   AAA   466/652
(71 %)
9 diff
(98.7 %id)
BU160675 melanotic melanoma, skin .a 2939 to 3746 1 to 819       819/879
(93 %)
13 diff
(98.6 %id)
CN394301 embryonic stem cells, cell lines H1, H7, andH9 .a 2949 to 3655 1 to 707       707/707
(100 %)
0 diff
(100 %id)
DA116956 cerebellum .a 2967 to 3501 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
CN394309 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2991 to 3627 1 to 637       637/637
(100 %)
0 diff
(100 %id)
AL539628 brain, fetal brain .a 2999 to 3903 1 to 906       906/906
(100 %)
10 diff
(98.9 %id)
BX433205 brain, fetal brain .a 2999 to 3871 877 to 1       879/877
(100 %)
21 diff
(97.7 %id)
DA100460 cerebellum .a 3002 to 3550 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA720480   .a 3012 to 3576 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB285220 uterus .a 3012 to 3545 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA855561 placenta .a 3014 to 3566 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA107772 cerebellum .a 3016 to 3563 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA098235 cerebellum .a 3021 to 3591 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA456854 tongue, tumor tissue .a 3028 to 3578 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BE085281 breast .a 3079 to 3482 423 to 21     Submitted on the opposite strand 403/592
(68 %)
2 diff
(99.7 %id)
BE085358 breast .a 3079 to 3448 374 to 6     Submitted on the opposite strand 369/510
(72 %)
2 diff
(99.7 %id)
BP351978   .a 3102 to 3684 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA404899 thalamus .a 3114 to 3689 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
TI_154153865   .a 3117 to 3758 80 to 720       641/655
(97 %)
6 diff
(99.1 %id)
TI_154180984   .a 3117 to 3968 73 to 925       853/853
(100 %)
19 diff
(97.8 %id)
TI_158439665   .a 3117 to 3536 97 to 516       420/679
(61 %)
4 diff
(99.5 %id)
DA196105 amygdala .a 3120 to 3684 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA416527 thalamus .a 3123 to 3668 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA218739 brain .a 3152 to 3691 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BQ324729 colon_ins .a 3171 to 3423 1 to 255       255/255
(100 %)
16 diff
(93.8 %id)
CX868503 embryonic stem .a 3213 to 3948 1 to 736     Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 736/736
(100 %)
0 diff
(100 %id)
DA106935 cerebellum .a 3234 to 3824 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
BQ227874 embryonal carcinoma, cell line, testis .a 3243 to 4099 1 to 866       866/872
(99 %)
20 diff
(97.8 %id)
TI_154160142   .a 3272 to 3822 81 to 630       550/551
(99 %)
6 diff
(99.0 %id)
BQ441717 embryonal carcinoma, cell line, testis .a 3292 to 4120 1 to 834       834/883
(94 %)
10 diff
(98.9 %id)
DA163001 amygdala .a 3297 to 3869 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB150144 thymus .a 3328 to 3904 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA100323 cerebellum .a 3330 to 3873 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
AW499625 lymph .a 3343 to 3554 1 to 212       212/212
(100 %)
16 diff
(92.5 %id)
TI_154153803   .a 3349 to 4005 68 to 727       660/660
(100 %)
26 diff
(96.1 %id)
TI_154156699   .a 3349 to 3861 79 to 591       513/513
(100 %)
2 diff
(99.7 %id)
TI_154175877   .a 3349 to 3905 89 to 645       557/898
(62 %)
8 diff
(99.2 %id)
TI_158439314   .a 3349 to 4032 80 to 761       682/683
(99 %)
17 diff
(97.6 %id)
BU167969 melanotic melanoma, cell line, skin .a 3353 to 4252 1 to 905       905/905
(100 %)
12 diff
(98.7 %id)
BQ681355 melanotic melanoma, cell line, skin .a 3353 to 4119 1 to 769       769/964
(79 %)
5 diff
(99.5 %id)
BQ681853 melanotic melanoma, cell line, skin .a 3353 to 4262 1 to 923       923/923
(100 %)
25 diff
(97.3 %id)
BQ680815 melanotic melanoma, cell line, skin .a 3353 to 4221 1 to 869       869/896
(96 %)
12 diff
(98.7 %id)
BU839270 melanotic melanoma, cell line, skin .a 3353 to 4223 1 to 887       852/918
(92 %)
16 diff
(98.3 %id)
DB100768 testis .a 3401 to 3972 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA761412 tongue .a 3414 to 3944 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
BP288640 lung .a 3416 to 3998 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB160213 thymus .a 3436 to 4038 2 to 604   capped   603/603
(100 %)
0 diff
(100 %id)
TI_154158613   .a 3443 to 3944 80 to 581       502/590
(85 %)
10 diff
(98.4 %id)
TI_154175424   .a 3443 to 3855 78 to 489       412/422
(97 %)
12 diff
(97.2 %id)
TI_154175472   .a 3443 to 3816 201 to 576       376/1032
(36 %)
10 diff
(99.1 %id)
TI_154175822   .a 3443 to 3828 80 to 467       388/408
(95 %)
15 diff
(96.4 %id)
TI_154181116   .a 3444 to 4299 79 to 932       854/855
(99 %)
19 diff
(97.8 %id)
BP351566   .a 3501 to 4129 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
DA097725 cerebellum .a 3538 to 4090 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA212551 brain .a 3563 to 4091 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
BU429530 lymph .a 3564 to 4081 8 to 525       518/525
(98 %)
6 diff
(98.9 %id)
TI_154149044   .a 3564 to 4282 72 to 789       718/718
(100 %)
11 diff
(98.5 %id)
TI_154150670   .a 3564 to 4350 81 to 861       781/797
(97 %)
23 diff
(97.2 %id)
TI_154155620   .a 3573 to 4049 83 to 559       477/477
(100 %)
0 diff
(100 %id)
TI_154155821   .a 3573 to 4007 80 to 514       435/435
(100 %)
2 diff
(99.6 %id)
TI_154156416   .a 3573 to 4120 80 to 627       548/608
(90 %)
7 diff
(98.9 %id)
TI_158439288   .a 3573 to 4247 81 to 754       674/676
(99 %)
17 diff
(97.5 %id)
TI_154149164   .a 3593 to 4217 28 to 633       611/704
(86 %)
30 diff
(95.8 %id)
TI_154166395   .a 3611 to 4095 80 to 564       485/485
(100 %)
2 diff
(99.6 %id)
DA755168   .a 3638 to 4180 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA032354   .a 3672 to 4233 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA096466 cerebellum .a 3674 to 4209 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
FN053521 breast carcinoma .a 3681 to 3751 71 to 1     Submitted on the opposite strand 71/71
(100 %)
0 diff
(100 %id)
CN394336 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3712 to 4262 1 to 551       551/551
(100 %)
0 diff
(100 %id)
DB095381 testis .a 3730 to 4284 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA854451 placenta .a 3738 to 4305 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB079290 testis .a 3738 to 4302 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB079316 testis .a 3738 to 4301 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA208364 brain .a 3762 to 4320 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB117691 thymus .a 3780 to 4334 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BU553451 ovary, teratocarcinoma, cell line .a 3805 to 4663 1 to 867       867/869
(99 %)
11 diff
(98.8 %id)
BU848947 ovary, teratocarcinoma, cell line .a 3805 to 4681 1 to 884       884/884
(100 %)
17 diff
(98.1 %id)
BU859115 ovary, teratocarcinoma, cell line .a 3805 to 4700 1 to 898       898/906
(99 %)
6 diff
(99.4 %id)
BE279906 choriocarcinoma, placenta .a 3852 to 4428 1 to 577       577/577
(100 %)
0 diff
(100 %id)
DB081591 testis .a 3875 to 4440 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA387653 thalamus .a 3877 to 4470 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
AL527616 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 3918 to 4985 1 to 1062       1062/1062
(100 %)
7 diff
(99.4 %id)
TI_154153341   .a 4020 to 4628 80 to 686       607/607
(100 %)
14 diff
(97.7 %id)
DA284438 corpus callosum .a 4032 to 4597 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
CO248979 Chondrosarcoma Lung Metastasis cell lines, lung .a 4036 to 4731 1 to 691       691/813
(84 %)
16 diff
(98.1 %id)
DA807924 brain .a 4064 to 4643 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BM453894 melanotic melanoma, skin .a 4089 to 4968 1 to 888       888/906
(98 %)
13 diff
(98.6 %id)
BU186735 epithelioid carcinoma, Pancreas .a 4119 to 5013 1 to 900       900/900
(100 %)
13 diff
(98.6 %id)
BG978570 colon_normal .a 4144 to 4316 13 to 181       173/181
(95 %)
10 diff
(94.5 %id)
CR988972 T-Lymphocytes .a 4147 to 5027 1 to 881       881/881
(100 %)
0 diff
(100 %id)
CR978070 T-Lymphocytes .a 4183 to 4917 1 to 737       736/737
(99 %)
5 diff
(99.4 %id)
BM917972 blood, natural killer cells, cell line .a 4187 to 5006 1 to 825       825/966
(85 %)
10 diff
(99.0 %id)
CB122657 Liver .a 4201 to 4780 1 to 580       580/580
(100 %)
0 diff
(100 %id)
CR994770 T-Lymphocytes .a 4238 to 5008 1 to 771       771/771
(100 %)
0 diff
(100 %id)
DA434974 tongue, tumor tissue .a 4256 to 4771 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
CN481529 eye .a 4309 to 4897 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BF796156 lymph, lymphoma, cell line .a 4384 to 5134 1 to 753       751/952
(78 %)
15 diff
(98.5 %id)
BQ951368 large cell carcinoma, lung .a 4386 to 5248 1 to 865       865/944
(91 %)
6 diff
(99.4 %id)
DB126309 thymus .a 4388 to 4959 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
CX873060 embryonic stem .a 4405 to 5200 1 to 796       796/796
(100 %)
0 diff
(100 %id)
BM469456 lymph, lymphoma, cell line .a 4417 to 5138 1 to 729       729/970
(75 %)
7 diff
(99.3 %id)
DB049165 testis .a 4458 to 5016 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
EC584879 Prostate .a 4476 to 4577 1 to 96       96/96
(100 %)
7 diff
(92.8 %id)
TI_154146284   .a 4495 to 5145 77 to 727       651/680
(95 %)
18 diff
(97.4 %id)
CX757340 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 4521 to 5183 1 to 663     Submitted on the opposite strand 663/663
(100 %)
0 diff
(100 %id)
DA784204 brain .a 4535 to 5113 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA259852 caudate nucleus .a 4538 to 5090 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
CF552191 Pooled muscle (cardiac and skeletal) .a 4546 to 5410 1 to 865       865/865
(100 %)
2 diff
(99.8 %id)
DA373528 thalamus .a 4547 to 5096 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA877066 Prostate .a 4547 to 5105 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BP358122 mammary gland .a 4550 to 5131 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA158128 amygdala .a 4552 to 5113 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
TI_154153799   .a 4571 to 5224 80 to 731       654/653
(100 %)
13 diff
(98.1 %id)
BM470151 lymph, lymphoma, cell line .a 4590 to 5549 1 to 967       967/1024
(94 %)
16 diff
(98.5 %id)
DA600878   .a 4610 to 5175 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
TI_57230118   .a 4675 to 5464 64 to 853       790/791
(99 %)
6 diff
(99.3 %id)
AL520826 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 4696 to 5542 1 to 847       847/847
(100 %)
0 diff
(100 %id)
BP291940 lung .a 4703 to 5273 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DA751246   .a 4704 to 5281 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
AA219378 brain, neuroepithelial cells .a 4705 to 5124 1 to 421     Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 421/421
(100 %)
7 diff
(98.4 %id)
DB037415 testis .a 4711 to 5277 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BP306371   .a 4716 to 5299 1 to 584       584/584
(100 %)
0 diff
(100 %id)
CX785060 human embryonic stem cells .a 4730 to 5303 1 to 574       574/574
(100 %)
0 diff
(100 %id)
BM542224 melanotic melanoma, skin .a 4735 to 5665 1 to 940       938/1037
(90 %)
23 diff
(97.8 %id)
BG425068 Kidney, renal cell adenocarcinoma .a 4741 to 5439 1 to 701       701/1133
(61 %)
12 diff
(99.0 %id)
BI094046 cervix .a 4747 to 5497 1 to 752       752/755
(99 %)
5 diff
(99.4 %id)
BI013583 lung_tumor .a 4772 to 5065 1 to 306       306/306
(100 %)
28 diff
(90.9 %id)
BG286382 bladder, transitional cell papilloma, cell line .a 4793 to 5496 1 to 702       702/702
(100 %)
4 diff
(99.5 %id)
BM451933 eye, retinoblastoma .a 4809 to 5575 13 to 782       770/882
(87 %)
14 diff
(98.5 %id)
DB103749 thymus .a 4813 to 5352 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BU164097 embryonal carcinoma, cell line, testis .a 4848 to 5727 1 to 888       888/907
(97 %)
29 diff
(96.9 %id)
DA158058 amygdala .a 4853 to 5429 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
AK026662 Human lung .a 4862 to 6801 1 to 1940   available from FLJ, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 1940/1940
(100 %)
3 diff
(99.9 %id)
DB013800 esophageal, tumor tissue .a 4864 to 5437 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BE743840 adenocarcinoma cell line, ovary .a 4887 to 5722 1 to 837       840/930
(90 %)
24 diff
(97.5 %id)
CX787931 human embryonic stem cells .a 4898 to 5706 1 to 809       809/809
(100 %)
0 diff
(100 %id)
DA142237 alzheimer cortex .a 4909 to 5452 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BF525592 brain, glioblastoma with EGFR amplification .a 4919 to 5676 1 to 752       752/804
(93 %)
14 diff
(98.3 %id)
DA463394   .a 4921 to 5459 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
TI_59381358   .a 4927 to 5774 92 to 949       858/858
(100 %)
36 diff
(95.9 %id)
TI_154178341   .a 4928 to 5525 92 to 690       599/599
(100 %)
19 diff
(96.9 %id)
TI_154178471   .a 4928 to 5439 81 to 594       514/562
(91 %)
33 diff
(94.2 %id)
TI_154178496   .a 4928 to 5257 81 to 409       329/635
(51 %)
8 diff
(98.8 %id)
TI_154137641   .a 4934 to 5676 78 to 815       738/864
(85 %)
29 diff
(96.7 %id)
BQ229520 embryonal carcinoma, cell line, testis .a 4970 to 5716 1 to 755       755/981
(76 %)
25 diff
(97.5 %id)
BU509316 leiomyosarcoma, uterus .a 4970 to 5731 1 to 765       765/971
(78 %)
12 diff
(98.8 %id)
TI_154138045   .a 4974 to 5559 74 to 661       588/588
(100 %)
12 diff
(98.0 %id)
AV690702 hepatocellular carcinoma .a 5050 to 5439 8 to 395       388/420
(92 %)
27 diff
(93.6 %id)
CX752840 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 5073 to 5782 1 to 710       710/710
(100 %)
2 diff
(99.8 %id)
BE541714 cervix .a 5075 to 5855 1 to 770       770/772
(99 %)
16 diff
(98.0 %id)
TI_154188185   .a 5081 to 6034 120 to 1065       946/953
(99 %)
42 diff
(95.6 %id)
DR759553 embryonic stem .a 5137 to 6020 1 to 884       884/884
(100 %)
0 diff
(100 %id)
TI_57243221   .a 5149 to 5728 128 to 705       578/717
(80 %)
23 diff
(96.8 %id)
DA590015 lung .a 5156 to 5717 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BI013588 lung_tumor .a 5169 to 5507 345 to 5       341/348
(97 %)
11 diff
(96.9 %id)
BU507961 leiomyosarcoma, uterus .a 5202 to 6201 1 to 1001       1001/1084
(92 %)
12 diff
(98.9 %id)
BQ071754 brain, neuroblastoma, cell line .a 5236 to 6036 1 to 810       810/1115
(72 %)
19 diff
(98.3 %id)
BI013560 lung_tumor .a 5247 to 5555 310 to 3       308/318
(96 %)
6 diff
(98.2 %id)
BQ217215 large cell carcinoma, lung .a 5248 to 6119 1 to 880       880/890
(98 %)
10 diff
(98.9 %id)
AU124264   .a 5269 to 6047 2 to 779   capped   778/785
(99 %)
2 diff
(99.8 %id)
AU123571   .a 5272 to 6088 2 to 824   capped   820/823
(99 %)
13 diff
(98.5 %id)
FN171421 breast carcinoma .a 5278 to 5364 1 to 88       88/88
(100 %)
1 diff
(98.9 %id)
BQ721457 sympathetic trunk .a 5283 to 6177 1 to 900       900/904
(99 %)
13 diff
(98.6 %id)
BQ649475 hepatocellular carcinoma, cell line, Liver .a 5288 to 6041 1 to 757       757/914
(82 %)
12 diff
(98.7 %id)
CV570386 cornea, eye .a 5334 to 5966 1 to 633       633/633
(100 %)
0 diff
(100 %id)
BU167646 eye, retinoblastoma .a 5336 to 6207 1 to 873       873/913
(95 %)
2 diff
(99.8 %id)
TI_154137321   .a 5358 to 6028 78 to 746       669/836
(80 %)
30 diff
(96.5 %id)
CB141078 Liver .a 5383 to 5979 1 to 597       597/597
(100 %)
0 diff
(100 %id)
CR610844 B cells (Ramos cell line) Cot 25-normalized .a 5384 to 6776 1 to 1393       1393/1393
(100 %)
0 diff
(100 %id)
BM042184 melanotic melanoma, cell line, skin .a 5408 to 6077 1 to 670   fully sequenced,   670/670
(100 %)
2 diff
(99.8 %id)
AF119874 Liver .a 5411 to 6801 1 to 1391   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 1391/1391
(100 %)
1 diff
(100.0 %id)
TI_59385810   .a 5445 to 5996 65 to 618       554/920
(60 %)
4 diff
(99.6 %id)
AW651725 cervical carcinoma cell line, cervix .a 5458 to 5979 1 to 522       522/522
(100 %)
0 diff
(100 %id)
BQ925527 sciatic nerve .a 5461 to 6205 1 to 746       746/920
(81 %)
5 diff
(99.5 %id)
TI_154187752   .a 5482 to 6168 124 to 809       686/913
(75 %)
33 diff
(96.4 %id)
AA100845 Pancreas .a 5483 to 5900 1 to 418   fully sequenced,   418/418
(100 %)
0 diff
(100 %id)
CX762100 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 5486 to 6221 1 to 733     Submitted on the opposite strand 733/817
(89 %)
15 diff
(98.2 %id)
BM739122 Ascites, stomach .a 5492 to 6048 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BM764609 Ascites, stomach .a 5492 to 6160 1 to 668       668/668
(100 %)
1 diff
(99.9 %id)
CX784411 human embryonic stem cells .a 5501 to 6295 1 to 795       795/797
(99 %)
4 diff
(99.5 %id)
BE378917 endometrium, adenocarcinoma cell line, uterus .a 5507 to 6329 1 to 822       822/848
(96 %)
13 diff
(98.5 %id)
BU535695 adenocarcinoma, cell line, breast .a 5515 to 6338 1 to 836       834/898
(92 %)
18 diff
(98.0 %id)
BM697360 eye, lens .a 5538 to 6079 1 to 542     Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 542/542
(100 %)
1 diff
(99.9 %id)
BP194607 brain .a 5584 to 6166 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA728274   .a 5612 to 6354 2 to 749   capped   748/800
(93 %)
6 diff
(99.3 %id)
CR607113 B cells (Ramos cell line) Cot 25-normalized .a 5618 to 6798 1 to 1181       1181/1181
(100 %)
0 diff
(100 %id)
AL041341 testis .a 5635 to 6319 1 to 685       685/685
(100 %)
1 diff
(99.9 %id)
TI_154142578   .a 5645 to 6286 80 to 724       643/649
(99 %)
39 diff
(94.0 %id)
TI_154143861   .a 5645 to 6168 84 to 607       524/524
(100 %)
1 diff
(99.9 %id)
BQ926710 large cell carcinoma, lung .a 5655 to 6561 1 to 906       906/906
(100 %)
6 diff
(99.4 %id)
BG289879 bladder, transitional cell papilloma, cell line .a 5662 to 6376 1 to 711       711/783
(90 %)
8 diff
(99.0 %id)
BE936490 nervous_tumor .a 5664 to 5771 1 to 106       106/111
(95 %)
5 diff
(95.5 %id)
BE746500 adenocarcinoma cell line, ovary .a 5666 to 6464 1 to 791       791/791
(100 %)
11 diff
(98.7 %id)
CX784181 human embryonic stem cells .a 5674 to 6287 1 to 614       614/614
(100 %)
0 diff
(100 %id)
CD515483 White Matter .a 5684 to 6493 1 to 815       815/886
(91 %)
5 diff
(99.5 %id)
BY996415   .a 5693 to 6416 15 to 736       722/736
(98 %)
7 diff
(99.1 %id)
EH332808   .a 5702 to 5767 1 to 66       66/66
(100 %)
0 diff
(100 %id)
AL583113 B cells from Burkitt lymphoma .a 5718 to 6759 1055 to 15       1041/1123
(92 %)
12 diff
(99.0 %id)
EL948919 eyeball .a 5724 to 6287 66 to 626       563/626
(89 %)
7 diff
(98.9 %id)
AL582136 B cells from Burkitt lymphoma .a 5740 to 6768 1029 to 1       1029/1029
(100 %)
4 diff
(99.7 %id)
AW674575 cervix .a 5741 to 6190 1 to 450       450/450
(100 %)
0 diff
(100 %id)
BM849980 stomach .a 5816 to 6465 1 to 650       650/650
(100 %)
0 diff
(100 %id)
BM849356 stomach .a 5816 to 6495 1 to 680       680/680
(100 %)
0 diff
(100 %id)
BM789607 stomach .a 5825 to 6493 1 to 669       669/669
(100 %)
0 diff
(100 %id)
BM547690 brain, hippocampus .a 5829 to 6773 1 to 956       956/1110
(86 %)
30 diff
(97.3 %id)
AA100791 Pancreas .a 5839 to 6269 433 to 1   fully sequenced,   433/433
(100 %)
3 diff
(99.4 %id)
AL520825 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 5869 to 6729 860 to 1       860/860
(100 %)
3 diff
(99.7 %id)
BQ437725 eye, retinoblastoma .a 5922 to 6753 1 to 837       837/903
(92 %)
12 diff
(98.7 %id)
TI_149295997   .a 5946 to 6801 922 to 79   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 844/967
(87 %)
12 diff
(98.8 %id)
AI871477 anaplastic oligodendroglioma, brain .a 5949 to 6805 858 to 1       858/859
(99 %)
18 diff
(98.0 %id)
TI_57233348   .a 5959 to 6760 31 to 830       800/830
(96 %)
10 diff
(98.8 %id)
BI906875 leukocyte .a 5964 to 6760 1 to 795       795/795
(100 %)
5 diff
(99.4 %id)
BF686227 leiomyosarcoma cell line, uterus .a 5975 to 6793 1 to 822   AAA   822/827
(99 %)
30 diff
(96.4 %id)
BG389888 embryonal carcinoma, cell line, testis .a 5988 to 6792 1 to 797       797/944
(84 %)
24 diff
(97.5 %id)
BU538359 adenocarcinoma, cell line, breast .a 6007 to 6757 1 to 753       753/878
(85 %)
9 diff
(99.0 %id)
BM050114 epithelioid carcinoma cell line, Pancreas .a 6008 to 6737 1 to 733       733/733
(100 %)
6 diff
(99.2 %id)
BQ710469 Spleen .a 6008 to 6717 1 to 711       711/944
(75 %)
23 diff
(97.6 %id)
BG260309 bladder, transitional cell papilloma, cell line .a 6010 to 6734 1 to 724       724/724
(100 %)
3 diff
(99.6 %id)
BM042752 melanotic melanoma, cell line, skin .a 6016 to 6730 741 to 23   fully sequenced,   719/741
(97 %)
2 diff
(99.8 %id)
TI_227715202   .a 6020 to 6806 872 to 89   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 784/938
(83 %)
3 diff
(99.7 %id)
BU625624 cell lines, Enchondroma .a 6020 to 6801 798 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 780/780
(100 %)
2 diff
(99.8 %id)
CN394294 embryonic stem cells, cell lines H1, H7, andH9 .a 6039 to 6761 12 to 734       723/734
(98 %)
0 diff
(100 %id)
TI_154111894   .a 6039 to 6805 856 to 91   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 766/909
(84 %)
9 diff
(99.1 %id)
BM040773 Kidney, Wilms' tumor, cell line .a 6044 to 6805 1 to 762   fully sequenced,   762/762
(100 %)
14 diff
(98.2 %id)
TI_227713786   .a 6044 to 6806 861 to 104   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 758/935
(81 %)
6 diff
(99.4 %id)
AW071445 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .a 6045 to 6806 761 to 1       761/766
(99 %)
35 diff
(95.5 %id)
AA055125 heart .a 6049 to 6447 1 to 406       404/407
(99 %)
12 diff
(97.1 %id)
TI_154123715   .a 6049 to 6806 894 to 140   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 755/944
(79 %)
73 diff
(92.3 %id)
BF526581 brain, glioblastoma with EGFR amplification .a 6050 to 6805 1 to 762       762/948
(80 %)
29 diff
(97.0 %id)
BM689324 eye, optic nerve .a 6051 to 6517 1 to 467   fully sequenced, Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 467/467
(100 %)
5 diff
(99.0 %id)
AI818417 adenocarcinoma, Pancreas .a 6054 to 6806 753 to 1       753/755
(99 %)
32 diff
(95.8 %id)
AI760387 B-cell, chronic lymphotic leukemia .a 6059 to 6804 747 to 5       743/747
(99 %)
18 diff
(97.6 %id)
TI_149286946   .a 6059 to 6806 804 to 58   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 747/1101
(67 %)
1 diff
(100.0 %id)
TI_154126016   .a 6059 to 6801 830 to 89   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 742/956
(77 %)
5 diff
(99.5 %id)
BM697440 eye, fetal eyes .a 6059 to 6578 1 to 520   fully sequenced, Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 520/520
(100 %)
0 diff
(100 %id)
BQ925186 large cell carcinoma, lung .a 6060 to 6805 1 to 746   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 746/746
(100 %)
0 diff
(100 %id)
BQ017863 lung, Metastatic Chondrosarcoma .a 6062 to 6805 758 to 15   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 744/744
(100 %)
0 diff
(100 %id)
CA313706 Human Lung Epithelial cells, lung .a 6065 to 6801 754 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 738/738
(100 %)
1 diff
(99.9 %id)
BU623978 cell lines, Enchondroma .a 6065 to 6806 759 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 741/741
(100 %)
2 diff
(99.8 %id)
CD365684 Alveolar Macrophage, lung .a 6065 to 6806 759 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 741/741
(100 %)
1 diff
(99.9 %id)
BQ014505 Chondrosarcoma, Left Pubic Bone .a 6066 to 6801 751 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 735/735
(100 %)
3 diff
(99.6 %id)
BM972351 lung .a 6066 to 6806 757 to 18   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 740/740
(100 %)
1 diff
(99.9 %id)
AI049979   .a 6068 to 6804 736 to 2       735/736
(99 %)
7 diff
(99.1 %id)
CA420054 Bone, Human Chondrosarcoma Cell Line .a 6068 to 6801 749 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 733/733
(100 %)
1 diff
(99.9 %id)
BU628942 cell lines, Chondrosarcoma .a 6068 to 6801 751 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 733/733
(100 %)
1 diff
(99.9 %id)
TI_154128783   .a 6069 to 6801 819 to 88   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 732/732
(100 %)
1 diff
(99.9 %id)
BF792585 adrenal cortex carcinoma, cell line, adrenal gland .a 6071 to 6793 1 to 719       719/737
(97 %)
14 diff
(98.2 %id)
BQ773918 Chondrosarcoma Grade II, Left Pelvis .a 6072 to 6805 751 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 733/733
(100 %)
1 diff
(99.9 %id)
AI051966 liver and spleen .a 6077 to 6801 725 to 1       725/725
(100 %)
7 diff
(99.1 %id)
CB070216 Pancreas, Purified pancreatic islet .a 6080 to 6351 1 to 272   fully sequenced,   272/272
(100 %)
2 diff
(99.3 %id)
BU622158 Cell Line, Chondrosarcoma .a 6080 to 6801 736 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 720/720
(100 %)
2 diff
(99.8 %id)
CD364556 Alveolar Macrophage, lung .a 6088 to 6806 736 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 718/718
(100 %)
1 diff
(99.9 %id)
CA417720 Chondrosarcoma Cell line .a 6090 to 6801 727 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 711/711
(100 %)
1 diff
(99.9 %id)
BE293812 adenocarcinoma cell line, colon .a 6094 to 6737 661 to 16       646/666
(96 %)
1 diff
(99.9 %id)
AI676150 Prostate .a 6096 to 6851 757 to 2       755/758
(99 %)
12 diff
(98.5 %id)
BF663608 B-cells, primary B-cells from tonsils (cell line) .a 6097 to 6789 1 to 694   AAA   694/930
(74 %)
14 diff
(98.5 %id)
BF856069 prostate_normal .a 6102 to 6505 418 to 15     Submitted on the opposite strand 404/418
(96 %)
1 diff
(99.8 %id)
AL562941 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 6104 to 7164 1053 to 1       1053/1089
(96 %)
20 diff
(98.2 %id)
AI827007 adenocarcinoma, Pancreas .a 6104 to 6802 697 to 1       697/697
(100 %)
9 diff
(98.8 %id)
BU628482 Bone, Enchondroma cell line .a 6115 to 6805 710 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 692/692
(100 %)
1 diff
(99.9 %id)
BE304919 adenocarcinoma cell line, colon .a 6116 to 6757 653 to 1       653/919
(71 %)
17 diff
(98.2 %id)
CX868425 embryonic stem .a 6118 to 6799 712 to 31   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 682/682
(100 %)
0 diff
(100 %id)
AI701967 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 6119 to 6801 681 to 1       681/681
(100 %)
11 diff
(98.4 %id)
AW795577 uterus .a 6122 to 6768 644 to 1       644/656
(98 %)
12 diff
(98.2 %id)
BQ026798 Chondrosarcoma, Left Pubic Bone .a 6131 to 6806 693 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 675/675
(100 %)
1 diff
(99.9 %id)
AA837413 germinal center B cell .a 6136 to 6807 694 to 22       673/700
(96 %)
17 diff
(97.6 %id)
TI_154103352   .a 6136 to 6801 746 to 81   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 666/989
(67 %)
0 diff
(100 %id)
CK725022 Chondrosarcoma, Left Pubic Bone .a 6136 to 6801 682 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 666/680
(97 %)
0 diff
(100 %id)
AW440407 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 6149 to 6802 654 to 1       654/654
(100 %)
3 diff
(99.6 %id)
CD175110 embryonic stem cells, WA01, passage 38 .a 6155 to 6801 10 to 655   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 646/655
(98 %)
6 diff
(99.1 %id)
AI860755 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 6155 to 6800 646 to 1       646/646
(100 %)
0 diff
(100 %id)
AL043088 testis .a 6160 to 6806 698 to 52   AAA Submitted on the opposite strand 647/647
(100 %)
3 diff
(99.6 %id)
CA429155 Cell Line, Chondrosarcoma .a 6162 to 6806 662 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 644/644
(100 %)
1 diff
(99.9 %id)
BF331981 breast .a 6163 to 6513 353 to 1       353/353
(100 %)
3 diff
(99.2 %id)
BU684055 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 6171 to 6801 647 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 631/631
(100 %)
0 diff
(100 %id)
CA412151 Knee, Osteoarthritic Cartilage .a 6174 to 6801 644 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 628/628
(100 %)
0 diff
(100 %id)
AW151086 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 6176 to 6807 633 to 2       632/633
(99 %)
9 diff
(98.6 %id)
CA416288 Chondrosarcoma Cell line .a 6177 to 6801 641 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 625/625
(100 %)
2 diff
(99.7 %id)
BM509073 insulinoma, Pancreas .a 6179 to 6801 623 to 1       623/623
(100 %)
0 diff
(100 %id)
CA308110 Alveolar Macrophage, lung .a 6179 to 6806 646 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 628/628
(100 %)
2 diff
(99.7 %id)
BQ230555 epithelioid carcinoma, Pancreas .a 6184 to 6806 1 to 623   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 623/623
(100 %)
0 diff
(100 %id)
BU632333 cell lines, Chondrosarcoma .a 6185 to 6804 635 to 16       620/635
(97 %)
1 diff
(99.9 %id)
BQ448528 Knee, Osteoarthritic Cartilage .a 6186 to 6801 629 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 611/611
(100 %)
3 diff
(99.6 %id)
BQ575240 Chondrosarcoma Grade II, Left Pelvis .a 6188 to 6801 632 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 614/620
(99 %)
2 diff
(99.7 %id)
BU949244 Pancreas, Purified pancreatic islet .a 6191 to 6801 611 to 1     Submitted on the opposite strand 611/611
(100 %)
5 diff
(99.2 %id)
BM705953 eye, lens .a 6191 to 6783 1 to 593   fully sequenced,   593/593
(100 %)
0 diff
(100 %id)
BI861743 breast, mammary adenocarcinoma, cell line .a 6193 to 6805 1 to 612   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 612/612
(100 %)
2 diff
(99.7 %id)
TI_57193128   .a 6193 to 6805 59 to 670   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 612/612
(100 %)
2 diff
(99.7 %id)
AW071494 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .a 6201 to 6801 600 to 1       600/607
(98 %)
10 diff
(98.4 %id)
AW167306 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 6204 to 6806 603 to 1       603/651
(92 %)
5 diff
(99.3 %id)
BE221350 malignant melanoma, metastatic to lymphnode, skin .a 6206 to 6801 595 to 1       595/595
(100 %)
2 diff
(99.7 %id)
AI690912 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 6212 to 6806 626 to 33   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 594/594
(100 %)
6 diff
(99.0 %id)
TI_154136958   .a 6213 to 6804 688 to 95       594/1204
(49 %)
15 diff
(98.8 %id)
TI_149295068   .a 6226 to 6806 669 to 89   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 581/953
(60 %)
0 diff
(100 %id)
BE858496 brain, glioblastoma (pooled) .a 6227 to 6801 575 to 1       575/575
(100 %)
0 diff
(100 %id)
TI_154135983   .a 6227 to 6801 671 to 92   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 580/654
(88 %)
22 diff
(96.7 %id)
AW075956 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 6233 to 6801 569 to 1       569/569
(100 %)
7 diff
(98.8 %id)
BE222850 brain, oligodendroglioma .a 6242 to 6802 561 to 1       561/561
(100 %)
0 diff
(100 %id)
BM695211 eye, optic nerve .a 6242 to 6799 1 to 558   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 558/558
(100 %)
2 diff
(99.7 %id)
BM701964.
matches multiple genes
eye, optic nerve .a 6242 to 6805 1 to 564   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base), also hits gene NDFIP1 564/564
(100 %)
0 diff
(100 %id)
AW673333 cervix .a 6245 to 6805 562 to 2       561/562
(99 %)
1 diff
(99.9 %id)
BG685634 B-cells, primary B-cells from tonsils (cell line) .a 6249 to 6806 1 to 558   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 558/558
(100 %)
1 diff
(99.9 %id)
CD251723 brain, Pituitary .a 6249 to 6806 1 to 558       558/559
(99 %)
1 diff
(99.9 %id)
AW673186 cervical carcinoma cell line, cervix .a 6251 to 6801 551 to 1       551/551
(100 %)
1 diff
(99.9 %id)
BE855606 brain, glioblastoma (pooled) .a 6254 to 6801 548 to 1       548/548
(100 %)
0 diff
(100 %id)
TI_227712698   .a 6254 to 6806 631 to 79   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 553/981
(56 %)
0 diff
(100 %id)
BM041526 Kidney, Wilms' tumor, cell line .a 6259 to 6755 500 to 3   fully sequenced,   498/500
(99 %)
0 diff
(100 %id)
BM664358 eye, lens .a 6259 to 6804 561 to 16   fully sequenced,   546/561
(97 %)
0 diff
(100 %id)
AW327799.
matches multiple genes
Burkitt lymphoma, lymph .a 6260 to 6801 564 to 21   AAA Submitted on the opposite strand, also hits gene LOC146880 544/544
(100 %)
6 diff
(98.9 %id)
AW105530 ovary, tumor, 5 pooled (see description) .a 6266 to 6806 541 to 1       541/541
(100 %)
2 diff
(99.7 %id)
TI_157602141   .a 6276 to 6804 643 to 111       533/1203
(44 %)
13 diff
(99.0 %id)
AI422757 brain, glioblastoma (pooled) .a 6281 to 6801 521 to 1       521/521
(100 %)
0 diff
(100 %id)
BF590102 pooled .a 6281 to 6804 527 to 4       524/527
(99 %)
0 diff
(100 %id)
DB369164   .a 6286 to 6806 533 to 1       531/565
(93 %)
22 diff
(96.2 %id)
TI_154135919   .a 6286 to 6799 606 to 93       514/742
(69 %)
7 diff
(99.1 %id)
CA429010 Cell Line, Chondrosarcoma .a 6286 to 6801 532 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 516/516
(100 %)
0 diff
(100 %id)
BF981077 duodenal adenocarcinoma, cell line, small intestine .a 6287 to 6801 1 to 515   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 515/515
(100 %)
0 diff
(100 %id)
BU729632.
matches multiple genes
eye, optic nerve .a 6287 to 6805 537 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base), also hits gene NDFIP1 519/519
(100 %)
0 diff
(100 %id)
TI_154089970   .a 6290 to 6799 628 to 118   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 511/558
(91 %)
34 diff
(94.0 %id)
TI_157602339   .a 6299 to 6804 602 to 97       506/603
(83 %)
2 diff
(99.7 %id)
AU158666 placenta .a 6302 to 6801 499 to 1       499/500
(99 %)
3 diff
(99.4 %id)
BE080591 breast .a 6303 to 6744 450 to 9     Submitted on the opposite strand 442/450
(98 %)
0 diff
(100 %id)
BI062317 uterus_tumor .a 6303 to 6772 469 to 1       469/469
(100 %)
5 diff
(99.0 %id)
TI_154134695   .a 6308 to 6804 602 to 97       504/1105
(45 %)
18 diff
(98.4 %id)
BM480050 embryonal carcinoma, cell line, testis .a 6317 to 6801 1 to 485   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 485/485
(100 %)
0 diff
(100 %id)
AW501311 lymph .a 6320 to 6693 7 to 380       374/380
(98 %)
0 diff
(100 %id)
TI_154156074   .a 6320 to 6807 80 to 567       488/494
(98 %)
11 diff
(97.8 %id)
CB069716 Pancreas, Purified pancreatic islet .a 6321 to 6800 480 to 1   fully sequenced,   480/480
(100 %)
0 diff
(100 %id)
BM666387 eye, optic nerve .a 6321 to 6805 502 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 484/484
(100 %)
1 diff
(99.8 %id)
AA876177 pooled germ cell tumors .a 6327 to 6808 481 to 1       481/481
(100 %)
1 diff
(99.8 %id)
AA563777 colon, tumor .a 6331 to 6807 477 to 1       477/477
(100 %)
3 diff
(99.4 %id)
AA978327 carcinoid, lung .a 6331 to 6800 469 to 1       469/469
(100 %)
3 diff
(99.4 %id)
AI421151 brain, glioblastoma (pooled) .a 6336 to 6796 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AI362744 anaplastic oligodendroglioma, brain .a 6346 to 6807 462 to 1       462/462
(100 %)
0 diff
(100 %id)
CB115934 Liver .a 6348 to 6799 479 to 28   AAA Submitted on the opposite strand 452/452
(100 %)
0 diff
(100 %id)
AW591427 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 6359 to 6806 486 to 40   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 447/447
(100 %)
6 diff
(98.7 %id)
AA961903 pooled germ cell tumors .a 6360 to 6804 442 to 1       442/442
(100 %)
3 diff
(99.4 %id)
AA596028 larynx .a 6366 to 6801 435 to 1       435/435
(100 %)
3 diff
(99.4 %id)
AA707867 pineal gland .a 6367 to 6799 430 to 1       430/430
(100 %)
4 diff
(99.1 %id)
EL951993 eyeball .a 6381 to 6793 36 to 451       416/451
(92 %)
7 diff
(98.5 %id)
AA548331 colon, tumor .a 6381 to 6802 421 to 1       421/426
(98 %)
1 diff
(99.8 %id)
AI148219 senescent fibroblast .a 6381 to 6804 430 to 7       424/432
(98 %)
0 diff
(100 %id)
AI571339 anaplastic oligodendroglioma, brain .a 6381 to 6801 437 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 421/427
(98 %)
2 diff
(99.6 %id)
TI_154136772   .a 6381 to 6806 484 to 59   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 426/1418
(30 %)
12 diff
(99.2 %id)
AW005591 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 6389 to 6802 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AA478566.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6393 to 6800 407 to 1     also hits gene PRDM4 407/407
(100 %)
1 diff
(99.8 %id)
AA134606 lung, lung carcinoma .a 6394 to 6802 1 to 408   fully sequenced,   408/408
(100 %)
1 diff
(99.8 %id)
AA219239 brain, neuroepithelial cells .a 6395 to 6801 434 to 25   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 410/419
(97 %)
5 diff
(98.9 %id)
AI858881 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 6395 to 6801 407 to 1       407/407
(100 %)
2 diff
(99.6 %id)
AA813193   .a 6401 to 6809 412 to 4       409/412
(99 %)
0 diff
(100 %id)
AA513041 Ewing's sarcoma .a 6401 to 6801 410 to 11   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 400/400
(100 %)
3 diff
(99.3 %id)
AA643594 colon, colon tumor RER+ .a 6402 to 6807 404 to 1       404/404
(100 %)
2 diff
(99.6 %id)
AI610775 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 6404 to 6806 403 to 1       403/403
(100 %)
0 diff
(100 %id)
CN394304 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 6413 to 6753 341 to 1     Submitted on the opposite strand 341/341
(100 %)
5 diff
(98.6 %id)
AA586629 germ cell tumor .a 6415 to 6804 394 to 5       390/394
(98 %)
0 diff
(100 %id)
AW083144 colon, moderately differentiated adenocarcinoma .a 6415 to 6801 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AA596034 larynx .a 6419 to 6801 383 to 1       383/383
(100 %)
0 diff
(100 %id)
AA806007 germinal center B cell .a 6419 to 6806 409 to 23   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 387/387
(100 %)
1 diff
(99.8 %id)
AI366932 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 6423 to 6801 377 to 1       377/377
(100 %)
2 diff
(99.5 %id)
AI289106 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 6425 to 6801 377 to 1       377/377
(100 %)
0 diff
(100 %id)
TI_154124895   .a 6426 to 7201 860 to 88   tiling clone, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 773/948
(81 %)
18 diff
(98.2 %id)
AI271538 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6427 to 6799 374 to 1       374/374
(100 %)
1 diff
(99.8 %id)
AI289216 2 pooled tumors (clear cell type), Kidney .a 6430 to 6807 380 to 3       378/380
(99 %)
0 diff
(100 %id)
AI049724   .a 6432 to 6804 373 to 1       373/377
(98 %)
0 diff
(100 %id)
CF529361 placenta .a 6434 to 6804 386 to 16       371/386
(96 %)
0 diff
(100 %id)
AU149956   .a 6435 to 6801 367 to 1       367/376
(97 %)
1 diff
(99.8 %id)
AI290432 adenocarcinoma, colon .a 6442 to 6807 368 to 1       368/368
(100 %)
2 diff
(99.5 %id)
BF512446   .a 6442 to 6806 382 to 18   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 365/365
(100 %)
0 diff
(100 %id)
BM990084 lung, Lung Focal Fibrosis .a 6446 to 6801 374 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 356/360
(98 %)
1 diff
(99.8 %id)
AI570907 adenocarcinoma, Pancreas .a 6453 to 6804 357 to 6       352/357
(98 %)
0 diff
(100 %id)
AI270714 colon, moderately-differentiated adenocarcinoma .a 6466 to 6806 341 to 1       341/341
(100 %)
0 diff
(100 %id)
AW293220   .a 6466 to 6801 351 to 16   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 336/336
(100 %)
3 diff
(99.2 %id)
H46823 brain .a 6467 to 6804 1 to 341       341/345
(98 %)
4 diff
(98.9 %id)
D51130   .a 6475 to 6801 325 to 1       325/325
(100 %)
2 diff
(99.4 %id)
AW802611 uterus .a 6479 to 6780 1 to 302       302/302
(100 %)
4 diff
(98.7 %id)
AW802614 uterus .a 6481 to 6783 311 to 9       303/313
(96 %)
0 diff
(100 %id)
AA622976 breast .a 6482 to 6801 320 to 1       320/320
(100 %)
0 diff
(100 %id)
T30305 testis .a 6484 to 6801 318 to 1       318/318
(100 %)
0 diff
(100 %id)
BU727432 eye, optic nerve .a 6487 to 6805 337 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 319/319
(100 %)
4 diff
(98.8 %id)
AW802456 uterus .a 6489 to 6783 303 to 9       295/303
(97 %)
0 diff
(100 %id)
AW802460 uterus .a 6489 to 6783 303 to 9       295/303
(97 %)
0 diff
(100 %id)
AI589831 anaplastic oligodendroglioma, brain .a 6490 to 6801 312 to 1       312/312
(100 %)
0 diff
(100 %id)
BI062629 uterus_tumor .a 6493 to 6772 280 to 1       280/282
(99 %)
0 diff
(100 %id)
AA653215   .a 6495 to 6806 311 to 1       311/311
(100 %)
4 diff
(98.8 %id)
BM713005 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6501 to 6799 1 to 299   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 299/299
(100 %)
1 diff
(99.7 %id)
BM727009 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6501 to 6801 1 to 301   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 301/301
(100 %)
0 diff
(100 %id)
BI063227 uterus_tumor .a 6508 to 6707 1 to 200       200/200
(100 %)
0 diff
(100 %id)
AI524665 adenocarcinoma, Pancreas .a 6519 to 6804 289 to 4       286/289
(98 %)
0 diff
(100 %id)
AI611219 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 6522 to 6807 286 to 2       285/286
(99 %)
0 diff
(100 %id)
BM668138 eye, lens .a 6522 to 6801 296 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 280/280
(100 %)
0 diff
(100 %id)
DB512326 testis .a 6524 to 6803 1 to 277     Submitted on the opposite strand 277/278
(99 %)
11 diff
(96.1 %id)
AA553985 colon .a 6524 to 6801 279 to 1       279/279
(100 %)
3 diff
(99.0 %id)
AI127010 heart .a 6533 to 6725 193 to 1       193/193
(100 %)
0 diff
(100 %id)
AA055045 heart .a 6545 to 6802 257 to 1       257/257
(100 %)
2 diff
(99.3 %id)
AI364637 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 6548 to 6807 261 to 2       260/261
(99 %)
0 diff
(100 %id)
BU735639 eye, fetal eyes .a 6548 to 6801 270 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 254/254
(100 %)
0 diff
(100 %id)
AI686352 Prostate .a 6552 to 6807 256 to 1       256/256
(100 %)
0 diff
(100 %id)
AV727347 hypothalamus .a 6564 to 6801 1 to 238   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 238/238
(100 %)
0 diff
(100 %id)
AW051077 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 6571 to 6806 236 to 1       236/237
(99 %)
1 diff
(99.6 %id)
AA133174 lung, lung carcinoma .a 6580 to 6802 223 to 1   fully sequenced,   223/223
(100 %)
2 diff
(99.2 %id)
AI539032 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 6586 to 6801 241 to 26   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 216/216
(100 %)
1 diff
(99.6 %id)
AI828866 pooled germ cell tumors .a 6592 to 6801 210 to 1       210/210
(100 %)
0 diff
(100 %id)
AW197391 pooled germ cell tumors .a 6592 to 6801 210 to 1       210/210
(100 %)
0 diff
(100 %id)
AI049748   .a 6603 to 6801 209 to 11   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 199/199
(100 %)
0 diff
(100 %id)
AW009720 colon .a 6607 to 6802 196 to 1       196/196
(100 %)
0 diff
(100 %id)
AA449101   .a 6630 to 6804 176 to 2       175/176
(99 %)
0 diff
(100 %id)
AA564040 colon, tumor .a 6639 to 6801 163 to 1       163/163
(100 %)
0 diff
(100 %id)
AI453514 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 6640 to 6801 162 to 1       162/162
(100 %)
0 diff
(100 %id)
ES314757 occipital scalp hair, skin .a 6642 to 6801 176 to 16   AAA Submitted on the opposite strand 161/161
(100 %)
1 diff
(99.4 %id)
AA593108 colon .a 6647 to 6802 156 to 1       156/156
(100 %)
0 diff
(100 %id)
BE350726 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 6668 to 7199 532 to 1       532/532
(100 %)
0 diff
(100 %id)
CA415920 Chondrosarcoma Cell line .a 6673 to 7201 545 to 17   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 529/529
(100 %)
0 diff
(100 %id)
BY998935   .a 7065 to 7200 1 to 136     Submitted on the opposite strand 136/138
(98 %)
1 diff
(99.3 %id)
CR614576 fetal brain .b 1 to 1643 4 to 1646   tiling clone,   1646/1646
(100 %)
0 diff
(100 %id)
AL567961 brain, fetal brain .b 752 to 1643 891 to 1       891/891
(100 %)
11 diff
(98.8 %id)
DB063722 testis .b 784 to 1322 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB155045 thymus .b 920 to 1510 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA811277 brain .b 1013 to 1588 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
CN360036 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1073 to 1701 629 to 1     Submitted on the opposite strand 629/629
(100 %)
2 diff
(99.7 %id)
DB277105 uterus .b 1100 to 1615 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
BI467327 Pancreas, Purified pancreatic islet .b 1117 to 1691 577 to 1       577/583
(98 %)
4 diff
(99.4 %id)
DA115037 cerebellum .b 1130 to 1691 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AI921706 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1147 to 1698 552 to 1       552/552
(100 %)
3 diff
(99.5 %id)
CF138234 lymph .b 1158 to 1586 7 to 435       429/435
(98 %)
6 diff
(98.7 %id)
TI_154168123   .b 1158 to 1756 92 to 695       604/892
(67 %)
12 diff
(98.7 %id)
BX101540 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1244 to 1696 468 to 15   AAA Submitted on the opposite strand 454/454
(100 %)
1 diff
(99.8 %id)
AI452836 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1324 to 1700 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AW117860 esophagus, squamous cell carcinoma .b 1364 to 1698 335 to 1       335/335
(100 %)
1 diff
(99.8 %id)
DB143602 thymus .b 1387 to 1950 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB134676 thymus .b 1529 to 2100 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA552238   .b 1569 to 2111 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
CR979749 T-Lymphocytes .b 1638 to 2339 1 to 703   tiling clone,   703/703
(100 %)
4 diff
(99.5 %id)
EL594372 epidermis, skin .b 1693 to 2430 742 to 9     Submitted on the opposite strand 734/821
(89 %)
12 diff
(98.6 %id)
CN394331 embryonic stem cells, cell lines H1, H7, andH9 .b 1705 to 2450 1 to 746   tiling clone,   746/746
(100 %)
0 diff
(100 %id)
DC424345   .b 1709 to 2386 1 to 680       680/757
(89 %)
4 diff
(99.5 %id)
BE250146 adenocarcinoma cell line, colon .b 1721 to 2555 37 to 854       822/854
(96 %)
41 diff
(95.2 %id)
BF890748 marrow .b 1725 to 2119 397 to 3     Submitted on the opposite strand 395/397
(99 %)
0 diff
(100 %id)
AF085356   .b 1735 to 4399 1 to 2665 V62E V66D V76A L77* tiling clone, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 2665/2665
(100 %)
13 diff
(99.6 %id)
BQ317498 colon .b 1737 to 2293 1 to 557       557/565
(98 %)
3 diff
(99.5 %id)
BE305088 adenocarcinoma cell line, colon .b 1739 to 2247 1 to 508       508/509
(99 %)
2 diff
(99.7 %id)
AL602364 human skeletal muscle .b 1757 to 2357 1 to 601       601/601
(100 %)
1 diff
(99.9 %id)
CT001965 T-Lymphocytes .b 1851 to 2541 1 to 700       697/715
(97 %)
12 diff
(98.4 %id)
AK303465 thymus .c 1 to 2637 1 to 2637 exact tiling clone,   2637/2637
(100 %)
9 diff
(99.7 %id)
DC409339 thymus .c 1 to 526 1 to 527       527/527
(100 %)
2 diff
(99.7 %id)
CA442246 lung, Lung Focal Fibrosis .d 1 to 570 19 to 587   tiling clone, Submitted on the opposite strand 569/569
(100 %)
1 diff
(99.9 %id)
BI047025 prostate_normal .d 402 to 956 561 to 6   tiling clone,   556/564
(98 %)
14 diff
(97.6 %id)
BX644883   .d 828 to 1004 1 to 177   tiling clone,   177/177
(100 %)
0 diff
(100 %id)
CB133365 Liver .e 1 to 575 1 to 575   tiling clone,   575/575
(100 %)
0 diff
(100 %id)
BG337943 leiomyosarcoma cell line, uterus .e 52 to 652 1 to 603   tiling clone,   603/756
(79 %)
15 diff
(98.1 %id)
BM820950 stomach .e 92 to 605 1 to 514   tiling clone,   514/514
(100 %)
0 diff
(100 %id)
AK021583 whole embryo, mainly head .f 1 to 1538 1 to 1538   tiling clone, available from FLJ, AAA   1538/1538
(100 %)
0 diff
(100 %id)
AK021418 whole embryo, mainly head .f 1431 to 4839 1 to 3409 exact tiling clone, available from FLJ,   3409/3409
(100 %)
1 diff
(100.0 %id)
AU116861 whole embryo, mainly head .f 1432 to 2034 2 to 603   capped   602/602
(100 %)
3 diff
(99.6 %id)
DB447359 testis .f 1447 to 1790 73 to 416       344/422
(81 %)
12 diff
(97.2 %id)
BF893228 marrow .f 1519 to 1947 468 to 41     Submitted on the opposite strand 428/468
(91 %)
3 diff
(99.4 %id)
CN394313 embryonic stem cells, cell lines H1, H7, andH9 .f 1692 to 1909 1 to 218       218/218
(100 %)
0 diff
(100 %id)
BM008317 Spleen .f 2599 to 3289 1 to 702       702/752
(93 %)
21 diff
(97.3 %id)
BM008191 Spleen .f 2599 to 3133 1 to 539       539/762
(70 %)
8 diff
(99.0 %id)
TI_59383582   .f 2600 to 3289 63 to 763       701/751
(93 %)
20 diff
(97.4 %id)
TI_59383671   .f 2600 to 3133 101 to 638       538/761
(70 %)
7 diff
(99.1 %id)
BQ709569 Spleen .f 2601 to 3557 1 to 978   tiling clone,   978/978
(100 %)
30 diff
(97.0 %id)
DB148711 thymus .f 2645 to 2995 2 to 353   capped   352/352
(100 %)
1 diff
(99.8 %id)
BE152475 head_neck .f 2835 to 3121 20 to 306       287/315
(91 %)
8 diff
(97.5 %id)
BE152476 head_neck .f 2855 to 3121 1 to 269       269/281
(95 %)
6 diff
(97.9 %id)
AU123830   .f 3011 to 3850 2 to 843   capped   842/842
(100 %)
8 diff
(99.1 %id)
EL955264 eyeball .f 3535 to 4061 24 to 545       522/545
(95 %)
6 diff
(98.9 %id)
BF760842 colon .f 3776 to 4064 290 to 1     Submitted on the opposite strand 290/290
(100 %)
1 diff
(99.7 %id)
BM153826 leukopheresis .f 4122 to 4489 1 to 368       368/368
(100 %)
14 diff
(96.2 %id)
BM193550 leukopheresis .f 4122 to 4446 1 to 326       326/326
(100 %)
7 diff
(97.9 %id)
AA825502 germinal center B cell .f 4267 to 4788 519 to 1       519/519
(100 %)
6 diff
(98.9 %id)
AU143838 whole embryo, mainly head .f 4369 to 4839 472 to 1       472/483
(97 %)
11 diff
(97.8 %id)
BF869422 lung_tumor .g 1 to 370 20 to 389 exact tiling clone,   382/389
(98 %)
6 diff
(98.5 %id)
BQ339668 nervous_normal .h-u 1 to 611 1 to 607   tiling clone,   607/612
(99 %)
23 diff
(96.3 %id)
BF954423 nervous_normal .h-u 211 to 777 567 to 2 V100A tiling clone,   566/568
(99 %)
0 diff
(100 %id)
BF732710 fibrotheoma, ovary .i 1 to 561 562 to 1   tiling clone,   562/562
(100 %)
2 diff
(99.7 %id)
AA521173 germinal center B cell .i 36 to 570 530 to 1   tiling clone,   530/550
(96 %)
9 diff
(98.4 %id)
BI438391 Pancreas, Purified pancreatic islet .i 258 to 370 1 to 113       113/113
(100 %)
3 diff
(97.4 %id)
DA120016 cerebellum .i 435 to 973 2 to 540 exact tiling clone, capped   539/539
(100 %)
1 diff
(99.9 %id)
DB163662 thymus .j 1 to 584 2 to 585 exact tiling clone, capped   584/584
(100 %)
0 diff
(100 %id)
AI953887 brain, three pooled meningiomas .k-u 1 to 500 500 to 1 exact tiling clone,   500/500
(100 %)
1 diff
(99.8 %id)
AA572737   .l-u 1 to 462 1 to 463 exact tiling clone,   463/463
(100 %)
5 diff
(99.0 %id)
BQ379285 uterus_tumor .m-u 1 to 191 189 to 1 S11R tiling clone,   189/189
(100 %)
2 diff
(99.0 %id)
AK090671 cerebellum Gene SNRNP200, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
AK303663 thymus Gene SNRNP200, variant not shown         Suspected internal deletion, this clone was ignored    
AW379429 head_neck Gene SNRNP200, variant not shown         This clone was ignored    
AX746566   Gene SNRNP200, variant not shown         Suspected internal deletion, this clone was ignored    
BQ301516 bocio_tumor Gene SNRNP200, variant not shown              
DA380076 thalamus Gene SNRNP200, variant not shown       capped This clone was ignored    
BX479872   Gene SNRNP200, variant not shown              
AA013420 eye, retina Gene SNRNP200, variant not shown              
AA015643 eye, retina Gene SNRNP200, variant not shown              
AA018684 eye, retina Gene SNRNP200, variant not shown              
AA018743 eye, retina Gene SNRNP200, variant not shown              
AA054130 eye, retina Gene SNRNP200, variant not shown              
AA054175 eye, retina Gene SNRNP200, variant not shown              
BF205236 muscle, rhabdomyosarcoma Gene SNRNP200, variant not shown         Suspected internal deletion, this clone was ignored    
BC131784 PCR rescued clones Gene SNRNP200, variant not shown         Suspected internal deletion, this clone was ignored    
AV750370 Pituitary Gene SNRNP200, variant not shown         Suspected internal deletion, this clone was ignored    
DA892085 rectum Gene SNRNP200, variant not shown       capped      
DC389196 Spleen Gene SNRNP200, variant not shown         Suspected internal deletion, this clone was ignored    
DC411081 thymus Gene SNRNP200, variant not shown         Suspected internal deletion, this clone was ignored    
DB221331 trachea Gene SNRNP200, variant not shown       capped      
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k-u, .l-u, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI